Heron Therapeutics (HRTX) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -4.07 | -1.50 | -2.12 | -17.2 | -10.7 | -9.99 | ||
| Changes by years, y/y, % | -52% | -63% | +42% | +709% | -38% | +4.6% | |||
Heron Therapeutics. P/E
Heron Therapeutics. P/E, changes, %
Heron Therapeutics (HRTX) P/E US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| P/E | ? | -17.3 | -43.4 | -342.5 | -15.8 | -10.7 | -9.99 | |
| Changes by years, y/y, % | +647% | +738% | +2 992% | +45% | -38% | |||
| Changes by quarters, q/q, % | +59% | +151% | +690% | -95% | -32% | |||